4.4 Article

Use of prescribed opioids before and after bariatric surgery: prospective evidence from a US multicenter cohort study

期刊

SURGERY FOR OBESITY AND RELATED DISEASES
卷 13, 期 8, 页码 1337-1346

出版社

ELSEVIER SCIENCE INC
DOI: 10.1016/j.soard.2017.04.003

关键词

Severe obesity; Bariatric surgery; Roux-en-Y gastric bypass; Laparoscopic adjustable gastric band; Medication; Opioid; Narcotic; Analgesia; Pain

类别

资金

  1. National institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [U01 DK066557, U01-DK66667, UL1-RR024996, U01-DK66568, M01 RR-00037, U01-DK66471, U01-DK66526, U01-DK66585, UL1-RR024153, U01-DK66555]

向作者/读者索取更多资源

Background: Limited evidence suggests bariatric surgery may not reduce opioid analgesic use, despite improvements in pain. Objective: To determine if use of prescribed opioid analgesics changes in the short and long term after bariatric surgery and to identify factors associated with continued and postsurgery initiated use. Setting: Ten U.S. hospitals. Methods: The Longitudinal Assessment of Bariatric Surgery-2 is an observational cohort study. Assessments were conducted presurgery, 6 months postsurgery, and annually postsurgery for up to 7 years until January 2015. Opioid use was defined as self-reported daily, weekly, or as needed use of a prescribed medication classified as an opioid analgesic. Results: Of 2258 participants with baseline data, 2218 completed follow-up assessment(s) (78.7% were female, median body mass index: 46; 70.6% underwent Roux-en-Y gastric bypass). Prevalence of opioid use decreased after surgery from 14.7% (95% CI: 13.3-16.2) at baseline to 12.9% (95% CI: 11.5-14.4) at month 6 but then increased to 20.3%, above baseline levels, as time progressed (95% CI: 18.2-22.5) at year 7. Among participants without baseline opioid use (n = 1892), opioid use prevalence increased from 5.8% (95% CI: 4.7-6.9) at month 6 to 14.2% (95% CI: 12.2-16.3) at year 7. Public versus private health insurance, more pain presurgery, undergoing subsequent surgeries, worsening or less improvement in pain, and starting or continuing nonopioid analgesics postsurgery were significantly associated with higher risk of postsurgery initiated opioid use. Conclusion: After bariatric surgery, prevalence of prescribed opioid analgesic use initially decreased but then increased to surpass baseline prevalence, suggesting the need for alternative methods of pain management in this population. (Surg 'Obes Relat Dis 2017;13:1337-1346.) (C) 2017 American Society for Bariatric Surgery. Published by Elsevier Inc. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Surgery

Changes in Smoking Behavior Before and After Gastric Bypass A 7-year Study

Wendy C. King, Gretchen E. White, Steven H. Belle, Susan Z. Yanovski, Alfons Pomp, Walter J. Pories, Bruce M. Wolfe, Bestoun Ahmed, Anita P. Courcoulas

Summary: The study evaluated smoking history and behavior changes in patients undergoing RYGB surgery over a 7-year period. The results showed that although most adults who smoked before surgery quit pre-surgery, smoking prevalence rebounded over 7 years primarily due to relapse. Risk factors for post-surgery smoking included smoking history, younger age, low household income, marital status, and illicit drug use.

ANNALS OF SURGERY (2022)

Article Gastroenterology & Hepatology

Prevalence and clinical features of patients with concurrent HBsAg and anti-HBs: Evaluation of the hepatitis B research network cohort

William M. Lee, Wendy C. King, Kathleen B. Schwarz, Jody Rule, Anna S. F. Lok

JOURNAL OF VIRAL HEPATITIS (2020)

Article Surgery

Reported nutrient intake over 7 years after Roux-en-Y gastric bypass in the Longitudinal Assessment of Bariatric Surgery-3 (LABS-3) psychosocial study

Susan K. Raatz, LuAnn K. Johnson, Alicia Caliquary, Wendy C. King, Melissa A. Kalarchian, Michael J. Devlin, Marsha D. Marcus, James E. Mitchell

SURGERY FOR OBESITY AND RELATED DISEASES (2020)

Review Surgery

Weight regain after bariatric surgery: a systematic literature review and comparison across studies using a large reference sample

Wendy C. King, Amanda S. Hinerman, Anita P. Courcoulas

SURGERY FOR OBESITY AND RELATED DISEASES (2020)

Article Immunology

Fatty Liver Disease in a Prospective North American Cohort of Adults With Human Immunodeficiency Virus and Hepatitis B Virus Coinfection

Mandana Khalili, Wendy C. King, David E. Kleiner, Mamta K. Jain, Raymond T. Chung, Mark Sulkowski, Mauricio Lisker-Melman, David K. Wong, Marc Ghany, Arun Sanyal, Richard K. Sterling

Summary: The study found that about 30% of HIV-HBV coinfected individuals had FLD, with 10% having steatohepatitis. FLD was associated with non-black race, metabolic risks, an atherogenic lipid profile, and elevated ALT over time. Identifying FLD and managing adverse metabolic profiles is crucial in HIV-HBV coinfection.

CLINICAL INFECTIOUS DISEASES (2021)

Article Surgery

Predictors of change in cardiovascular disease risk and events following gastric bypass: a 7-year prospective multicenter study

Amanda S. Hinerman, Samar R. El Khoudary, Abdus S. Wahed, Anita P. Courcoulas, Emma J. M. Barinas-Mitchell, Wendy C. King

Summary: This study identified multiple preoperative factors associated with changes in cardiovascular risk and events following Roux-en-Y gastric bypass surgery, providing insights into patients who may benefit more from the procedure and those who may require additional support for cardiovascular health improvement.

SURGERY FOR OBESITY AND RELATED DISEASES (2021)

Article Immunology

Preprocedural SARS-CoV-2 Testing to Sustain Medically Needed Health Care Delivery During the COVID-19 Pandemic: A Prospective Observational Study

Ghady Haidar, Ashley Ayres, Wendy C. King, Mackenzie McDonald, Alan Wells, Stephanie L. Mitchell, Andrew L. Bilderback, Tami Minnier, John W. Mellors

Summary: The study implemented a preprocedural screening initiative for SARS-CoV-2, revealing low infection rates (0.24% overall) that increased during COVID-19 surges. Additional studies are required to define the epidemiological threshold for universal preprocedural screening.

OPEN FORUM INFECTIOUS DISEASES (2021)

Article Gastroenterology & Hepatology

Performance of Serum-Based Scores for Identification of Mild Hepatic Steatosis in HBV Mono-infected and HBV-HIV Co-infected Adults

Richard K. Sterling, Wendy C. King, Mandana Khalili, David E. Kleiner, Amanda S. Hinerman, Mark Sulkowski, Raymond T. Chung, Mamta K. Jain, Mauricio Lisker-Melman, David K. Wong, Marc G. Ghany

Summary: This study evaluated the diagnostic performance of four noninvasive serum-based scores for detecting hepatic steatosis in chronic HBV cohorts, showing moderate diagnostic efficacy. The relative utility of these scores differed by co-infection/anti-HBV medication status, with population-specific cutoffs providing only moderate utility.

DIGESTIVE DISEASES AND SCIENCES (2022)

Article Gastroenterology & Hepatology

Hepatic Steatosis and Steatohepatitis in a Large North American Cohort of Adults With Chronic Hepatitis B

Mandana Khalili, David E. Kleiner, Wendy C. King, Richard K. Sterling, Marc G. Ghany, Raymond T. Chung, Atul K. Bhan, Philip Rosenthal, Mauricio Lisker-Melman, Rageshree Ramachandran, Anna S. Lok

Summary: In a large North American cohort of chronic hepatitis B patients, nearly a third had fatty liver disease, with 13% having steatohepatitis. Steatohepatitis was associated with advanced fibrosis and increased hepatic inflammation markers over time, highlighting the importance of screening and managing metabolic abnormalities to prevent disease progression in HBV patients.

AMERICAN JOURNAL OF GASTROENTEROLOGY (2021)

Article Gastroenterology & Hepatology

A Prospective Study Evaluating Changes in Histology, Clinical and Virologic Outcomes in HBV-HIV Co-infected Adults in North America

Richard K. Sterling, Wendy C. King, Mandana Khalili, Raymond T. Chung, Mark Sulkowski, Mamta K. Jain, Mauricio Lisker-Melman, Marc G. Ghany, David K. Wong, Amanda S. Hinerman, Atul K. Bhan, Abdus S. Wahed, David E. Kleiner

Summary: In a North American cohort of adults with HBV-HIV on cART with virological suppression, clinical outcomes and worsening histological disease were uncommon.

HEPATOLOGY (2021)

Article Gastroenterology & Hepatology

Clinical significance of quantitative e antigen in a cohort of hepatitis B virus-infected children and adults in North America

Stewart L. Cooper, Wendy C. King, Douglas B. Mogul, Marc G. Ghany, Kathleen B. Schwarz

Summary: The study found that the level of circulating HBeAg is associated with the degree of liver injury in HBeAg-positive CHB patients, as well as with race and age. In Asians, qHBeAg was inversely related to age, with a less clear relationship in Blacks and Whites. Additionally, regardless of sex, age, race, and HBV genotype, qHBeAg was higher in participants with predominant wild-type viral variants.

JOURNAL OF VIRAL HEPATITIS (2021)

Editorial Material Surgery

Comment on: Feasibility study on elimination of all oral opioids following bariatric surgery

Wendy C. King

SURGERY FOR OBESITY AND RELATED DISEASES (2021)

Article Gastroenterology & Hepatology

Comparison of HBV RNA and Hepatitis B Core Related Antigen With Conventional HBV Markers Among Untreated Adults With Chronic Hepatitis B in North America

Marc G. Ghany, Wendy C. King, Mauricio Lisker-Melman, Anna S. F. Lok, Norah Terrault, Harry L. A. Janssen, Mandana Khalili, Raymond T. Chung, William M. Lee, Daryl T. Y. Lau, Gavin A. Cloherty, Richard K. Sterling

Summary: The study found that HBV RNA and HBcrAg are moderately strongly correlated with HBV DNA levels, and the levels of these two markers also have certain correlations with clinical disease indicators for both HBeAg+ and HBeAg- phases of chronic hepatitis B patients.

HEPATOLOGY (2021)

Article Gastroenterology & Hepatology

Hepatitis B e antigen loss in adults and children with chronic hepatitis B living in North America: A prospective cohort study

William M. Lee, Wendy C. King, Harry L. A. Janssen, Marc G. Ghany, Robert J. Fontana, Michael Fried, Richard K. Sterling, Jordan J. Feld, Junyao Wang, Douglas B. Mogul, Stewart L. Cooper, Adrian M. Di Bisceglie

Summary: This study investigated the rate and predictors of HBeAg loss in patients with chronic hepatitis B viral infection. The findings suggest that specific demographic, clinical, and viral characteristics can impact the rate of HBeAg loss, which may be valuable for future therapeutic studies.

JOURNAL OF VIRAL HEPATITIS (2021)

Letter Gastroenterology & Hepatology

Untitled Reply

Marc G. Ghany, Wendy C. King, Mauricio Lisker-Melman, Anna S. F. Lok, Norah Terrault, Harry L. A. Janssen, Mandana Khalili, Raymond T. Chung, William M. Lee, Daryl T. Y. Lau, Gavin A. Cloherty, Richard K. Sterling

HEPATOLOGY (2022)

暂无数据